Collecting and reporting data on patients receiving stem cell transplants
The Prospective Collection, Storage and Reporting of Data on Patients
This study is trying to gather and share information about patients getting stem cell transplants for blood cancers to better understand how well these treatments work.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2000 (estimated) |
| Ages | 18 Years to 120 Years |
| Sex | All |
| Sponsor | Wake Forest University Health Sciences Academic / other |
| Locations | 1 site (Winston-Salem, North Carolina) |
| Trial ID | NCT01890486 on ClinicalTrials.gov |
What this trial studies
This study aims to systematically collect, analyze, and report data on patients undergoing hematopoietic stem cell transplantation, either autologous or allogeneic, for various hematological malignancies. It focuses on patients receiving standard preparative regimens, ensuring that the data collected adheres to IRB-approved protocols. The goal is to enhance understanding of treatment efficacy in cases where specific research questions are not being addressed.
Who should consider this trial
Good fit: Ideal candidates include patients scheduled for standard intensive therapy followed by either autologous or allogeneic stem cell transplantation.
Not a fit: Patients currently participating in other treatment research protocols may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve patient outcomes by providing valuable data that informs future treatment protocols for stem cell transplantation.
How similar studies have performed: While this approach is observational and may not directly test new interventions, similar studies have successfully contributed to the understanding of treatment outcomes in hematopoietic stem cell transplantation.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Planned standard of care dose intensive therapy and either an allogeneic or autologous bone marrow transplant Exclusion Criteria: Participation in any other treatment research protocol
Where this trial is running
Winston-Salem, North Carolina
- Wake Forest Baptist Health — Winston-Salem, North Carolina, United States (Recruiting)
Study contacts
- Principal investigator: Dianna Howard, MD — Wake Forest University Health Sciences
- Study coordinator: Dianna Howard, MD
- Email: dhoward@wakehealth.edu
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.